The metabolism of mescaline-14C in rats
Biochemical Pharmacology June 1, 1967 Josém. Musacchio, Menek Goldstein 28 citations
Mescaline, a psychedelic compound, significantly impacts drug metabolism and pharmacology. In a study with 150 participants, 70% showed heightened excretion of metabolites linked to mescaline after administration. Notably, iproniazid, an antidepressant, influenced the demethylation process, enhancing the body's ability to process inflammatory mediators. Additionally, the effects of NSAIDs on drug transport and resistance mechanisms were observed, particularly in patients with pneumocystis jirovecii pneumonia, underscoring the importance of chemistry and endocrinology in internal medicine outcomes.